Increased use of X-rays leads to earlier lung cancer diagnosis: study
A study found a "significant" link between the frequency of chest X-ray referrals and improved survival rates for lung cancer ...
Medscape9h
Subcutaneous Pembro on Par With IV Administration in Lung Cancer
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...
Fierce Biotech3d
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
Fierce Pharma5d
J&J combo signals new era in EGFR lung cancer with survival win against AstraZeneca's Tagrisso
Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for ...
South Carolina Public Radio8h
Advances in lung cancer treatment
This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...
News Medical on MSN6d
More chest X-rays in GP practices lead to better lung cancer survival rates
A groundbreaking study has revealed a significant link between the frequency of chest x-ray referrals from GPs and earlier diagnosis and improved survival rates for lung cancer patients.
Healio11d
TNF inhibitors do not significantly impact survival in lung, prostate colorectal cancer
TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...
CURE6d
First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
Johnson & Johnson's MARIPOSA study shows Rybrevant plus Lazcluze significantly extends overall survival in first-line ...
PharmaTimes4d
Amivantamab plus lazertinib shows survival benefit in lung cancer
Janssen-Cilag International NV has announced results from the phase 3 MARIPOSA study, demonstrating a significant overall survival benefit for patients with EGFR-mutated advanced non-small cell lung ...